AMY ISABELLE: Open Payments
NPI 1568084093 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 68 payments from 12 companies in 2025. Trend: 2023 $455 · 2024 $705 · 2025 $1,697
Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $377 |
| ViiV Healthcare Company | 15 | $287 |
| Janssen Pharmaceuticals, Inc | 5 | $182 |
| Merck Sharp & Dohme LLC | 10 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $150 |
| Alkermes, Inc. | 2 | $130 |
| Neurocrine BioSciences, Inc. | 5 | $129 |
| Gilead Sciences, Inc. | 5 | $120 |
| Exact Sciences Corporation | 4 | $72 |
| Braeburn Inc. | 2 | $37 |
Products named: MAVYRET, INVEGA SUSTENNA, DOVATO, PIFELTRO, CAPLYTA, VRAYLAR, VIVITROL, INGREZZA.
Industry payments across PA — which companies pay providers there.
